BSEInsider Trading / SAST13 Aug 2026 · 13 Aug 2026, 03:50 pm

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Metz Advisory LLP & PACs

Metropolis Healthcare Ltd · 542650

✦ AI SummaryPledge

Metropolis Healthcare Ltd's promoter group has sold 10,50,000 shares through open market sale on August 11, 2026, representing 0.51% of the company's shareholding.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

7DBAB101_35B4_44B7_9814_E1D3F38469BD_155047.pdf

pdf

Download →
View document text
Metz Advisory LLP Mumbai, Maharashtra To, To, To, BSE Limited, National Stock Exchange of India Limited, Metropolis Healthcare Limited Scrip Code: 542650 Symbol: METROPOLIS Dear Sir/Madam, Subject: Disclosure pursuant to Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 We, Metz Advisory LLP, promoter of Metropolis Healthcare Limited (“Target Company”), wish to inform you that we have sold 10,50,000 (Ten Lakh Fifty Thousand) Equity Shares of the Target Company (representing 0.51% of shareholding of the Target Company) through open market sale on August 11, 2026. Accordingly, enclosed herewith is the requisite disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Kindly take the same on record. Thanking you, Yours faithfully, For Metz Advisory LLP (Promoter) Ameera Shah Designated Partner DPIN: 00208095 Place: Mumbai Date: August 13, 2026 Metz Advisory LLP Mumbai, Maharashtra Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company (TC) Metropolis Healthcare Limited Seller: Name(s) of the acquirer/ seller and Persons Metz Advisory LLP (Promoter) Acting in Concert (PAC) with the acquirer/ seller Person Acting in Concert (PAC): Promoters: Dr. Sushil Shah Ms. Ameera Shah Sushil Shah Family Trust Promoter Group: Duru Shah Family Trust Dr. Duru Sushil Shah Mayur Shah Whether the acquirer/ seller belongs to Yes (Promoter Group) Promoter/ Promoter group Name(s) of the Stock Exchange(s) where the - BSE Limited and shares of TC are Listed - National Stock Exchange of India Limited Number % w.r.t. total share/ % w.r.t. total Details of the acquisition/ disposal as follows voting capital diluted share/ wherever applicable voting capital of (*) the TC (**) Before the disposal under consideration, holding of transferor and PACs: a) Shares carrying voting rights Seller – 6,27,64,864 Seller – 30.26 % Seller – 30.26 % #Together with #Together with #Together with PACs- 10,13,11,984 PACs - 48.85 % PACs - 48.85 % b) Shares in the nature of encumbrance Seller – 12,00,000 Seller – 12,00,000 Seller – 12,00,000 (pledge/ lien/ non-disposal Together with Together with Together with undertaking/ others) PACs - 12,00,000 PACs - 0.58 % PACs - 0.58 % c) Voting rights (VR) otherwise than by NIL NIL NIL shares Nil Nil 36,83,760 NA 7.193 Metz Advisory LLP Mumbai, Maharashtra d) Warrants/ convertible securities/ any NIL NIL NIL other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) Seller – 6,27,64,864 Seller – 30.26 % Seller – 30.26 % #Together with #Together with #Together with PACs - 10,13,11,984 PACs - 48.85 % PACs - 48.85 % Details of acquisition/ sale: 4 8.85 % 4 9.75 % a) Shares carrying voting rights acquired/ Seller - 10 ,50,000 Seller - 0.51 % Seller - 0.51 % sold b) VRs acquired/ sold otherwise than by NIL NIL NIL shares c) Warrants/ convertible securities/ any other instrument that entitles the NIL NIL NIL acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/ sold NIL NIL NIL d) Shares encumbered/ invoked/ released by the acquirer Seller - 10,50,000 Seller - 0.51 % Seller - 0.51 % e) Total (a+b+c+/-d) After the acquisition/ sale, holding of: Seller – 6,17,14,864 Seller – 29.76 % Seller – 29.76 % a) Shares carrying voting rights #Together with #Together with #Together with PACs – 9,92,11,984^ PACs - 47.84 %^ PACs - 47.84 %^ b) Shares encumbered with the acquirer Seller – 12,00,000 Seller – 12,00,000 Seller – 12,00,000 Together with Together with Together with PACs - 12,00,000 PACs - 0.58 % PACs - 0.58 % c) VRs otherwise than by shares NIL NIL NIL Metz Advisory LLP Mumbai, Maharashtra d) Warrants/ convertible securities/ any NIL NIL NIL other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/ sold e) Total (a+b+c+/-d) Seller – 6,17,14,864 Seller – 29.76 % Seller – 29.76 % #Together with #Together with #Together with PACs – 9,92,11,984^ PACs - 47.84 %^ PACs - 47.84 %^ 48.35 % Mode of acquisition/ sale (e.g. open market/ Open Market. 48.35 % off-market/ public issue/ rights issue/ 48.35 % preferential allotment/ inter-se transfer etc). Date of acquisition/ sale of shares/ VR or August 11, 2026 date of receipt of intimation of allotment of shares, whichever is applicable Equity share capital/ total voting capital of 20,73,87,568 Equity Shares of face value INR 2/- each aggregating the TC before the said acquisition/ sale to INR 41,47,75,136/- Equity share capital/ total voting capital of 20,73,87,568 Equity Shares of face value INR 2/- each aggregating the TC after the said acquisition/ sale to INR 41,47,75,136/- Total diluted share/ voting capital of the TC 20,73,87,568 Equity Shares of face value INR 2/- each aggregating after the said acquisition/ sale to INR 41,47,75,136/- # Includes 12,00,000 pledged Equity Shares ^ Includes the sale of 10,50,000 equity shares of the Target Company by Duru Shah Family Trust, executed on August 11, 2026. (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange. Note: Subsequent to the shareholding pattern filed by the Company with the Stock Exchanges for the quarter ended June 30, 2026, the Company allotted 36,900 and 18,700 Equity Shares pursuant to Metropolis – Restrictive Stock Unit Plan, 2020, on July 09, 2026 and August 04, 2026, respectively. Accordingly, the shareholding percentages have been calculated based on the total number of Equity Shares of the Company outstanding as on the date of the trade. (**) Diluted share/ voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/ warrants into equity shares of the TC. Signature of the Seller For Metz Advisory LLP (Promoter) Ameera Shah Designated Partner DPIN: 00208095 Place: Mumbai Date: August 13, 2026 ******